A systematic review of definitions of extreme phenotypes of HIV control and progression
Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection
Exosomes from breast milk inhibit HIV-1 infection of dendritic cells and subsequent viral transfer to CD4+ T cells
Incomplete adherence to antiretroviral therapy is associated with higher levels of residual HIV-1 viremia
Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons
Cellular HIV reservoir replenishment is not affected by blip or intermittent viremia episodes during darunavir/ritonavir monotherapy
Antiretroviral therapy increases thymic output in children with HIV
High rates of anal dysplasia in HIV-infected men who have sex with men, women, and heterosexual men
CD4+ cell count, viral load, and drug resistance patterns among heterosexual breakthrough HIV infections in a study of oral preexposure prophylaxis
‘If I am given antiretrovirals I will think I am nearing the grave’
HIV-1 subtype C is not associated with higher risk of heterosexual HIV-1 transmission
The effect of tuberculosis treatment on virologic and CD4+ cell count response to combination antiretroviral therapy
Cause-specific mortality among HIV-infected individuals, by CD4+ cell count at HAART initiation, compared with HIV-uninfected individuals
Treatment as long-term prevention
Beneficial impact of antiretroviral therapy on non-AIDS mortality
Extremely low and sustained HIV incidence among people who inject drugs in a setting of harm reduction
The tyrosine kinase inhibitor Dasatinib blocks in-vitro HIV-1 production by primary CD4+ T cells from HIV-1 infected patients
WHO ‘Treatment as Prevention’ guidelines are unlikely to decrease HIV transmission in the UK unless undiagnosed HIV infections are reduced
Tumor growth inhibition by ritonavir
Telaprevir therapy, renal impairment, and their effects on the pharmacokinetics of tenofovir in HIV/hepatitis C virus coinfected patients
Pharmacokinetics, safety and transplacental passage of rilpivirine in pregnancy
Gut disruption in HIV-2 infection despite reduced viremia